baber/WOPTO huggingface dataset:
Patent CA-3170186-A1 (CA)
Title: Multi-purpose robots and computer program products, and methods for operating the same
Inventor: GILDERT SUZANNE
IPC: B25J9/18
Filed: 2022-08-09
Abstract: Robots, methods, and computer program products for training and operating (semi-)autonomous robots to complete multiple different work objectives are described. A robot accesses a library of reusable work primitives from a catalog of libraries of reusable work primitives, each reusable work primitive corresponding to a respective basic sub-task or sub-action that the robot is operative to autonomously perform. A work objective is analyzed to determine a sequence (i.e., a combination and/or permutation) of reusable work primitives that, when executed by the robot, will complete the work objective. The robot executes the sequence of reusable work primitives to complete the work objective. A robot can be deployed with an appropriate stored library (or access to an appropriate library) of reusable work primitives, based on what the robot is expected to do, or what service category or role the robot will operate in.
Patent CA-3170897-A1 (CA)
Inventor: FLUTY DAREN E
IPC: A63G31/02
Filed: 2021-03-22
Abstract: Un système d'attraction de parc d'attractions comporte un trajet d'utilisateur s'étendant à travers au moins une partie du système d'attraction de parc d'attractions, un garde-corps s'étendant le long du trajet d'utilisateur et une plateforme accouplée de façon coulissante et rotative au garde-corps. La plateforme est configurée pour réaliser une translation le long du garde-corps pour positionner la plateforme par rapport au trajet d'utilisateur, et la plateforme est configurée pour tourner par rapport au trajet d'utilisateur pour s'ajuster entre une configuration rangée et une configuration déployée.
Patent CA-3171150-A1 (CA)
Inventor: WILLIAMS MATTHEW
IPC: H04L12/66
Filed: 2018-10-12
Abstract: A dedicated network gateway device capable of bridging, switching or routing network traffic between a traditional network and a direct interconnect network is provided. The device may include a host interface card having a first port, second port, and one or more computation devices. The first port may be a direct interconnect port connected to a direct interconnect network. The second port may be a traditional network port connected to switches and devices in the traditional network. The computation devices may be internally connected to the first and second ports. The host interface card may be connected to a host device via a communication bus. The host interface card may be capable of switching network traffic between the traditional and direct interconnect networks without intervention by the host device.
Patent CA-3172695-A1 (CA)
Inventor: LEUNG JACKIE
IPC: A61B18/14
Filed: 2021-04-14
Abstract: L'invention concerne un dispositif de lacération destiné à être utilisé dans des procédures médicales comprenant un arbre ayant des parties proximale et distale opposées. Une pince s'étend à partir de la partie distale. La pince comprend des premier et second bras de pince. La pince est mobile entre des positions ouverte et fermée. Dans la position ouverte, le premier bras de pince est espacé du second bras de pince. Dans la position fermée, le premier bras de pince est déplacé vers le second bras de pince. Un actionneur de pince est relié à la pince par l'intermédiaire de l'arbre et peut être manipulé pour déplacer la pince entre les positions ouverte et fermée. Une électrode radiofréquence (RF) est associée au premier bras de pince. L'électrode RF a une première surface de perforation qui est positionnée pour faire face au second bras de pince lorsque la pince est dans la position fermée. Un connecteur électrique s'étend de manière proximale à partir de l'électrode RF pour être connecté à une source d'alimentation.
Patent CA-3172862-A1 (CA)
Title: Substituted piperidino compounds and related methods of treatment
Inventor: PENNINGTON LEWIS D
IPC: C07D401/06
Filed: 2021-12-21
Abstract: The present invention provides compounds useful for the treatment of narcolepsy or cataplexy in a subject in need thereof. Related pharmaceutical compositions and methods are also provided herein.
Patent CA-3178457-A1 (CA)
Inventor: GUTMANN BERND
IPC: A61B34/10
Filed: 2021-03-25
Abstract: Des première et seconde images de segments d'une structure anatomique ayant un fixateur attaché sont affichées. Des indications peuvent être reçues en provenance d'emplacements de charnière dans la première image d'une pluralité de charnières du fixateur dans la première image. Des emplacements projetés de charnière dans la seconde image peuvent être déterminés sur la base, au moins en partie, des emplacements de charnière dans la première image. Des charnières candidates peuvent être détectées dans la seconde image ayant des formes associées à la pluralité de charnières. Les charnières candidates peuvent être détectées par un logiciel informatique à l'aide de techniques automatisées d'analyse d'image basée sur un logiciel. Des emplacements ajustés de charnière dans la seconde image peuvent ensuite être calculés sur la base, au moins en partie, des emplacements projetés de charnière dans la seconde image et des emplacements candidats de charnière dans la seconde image. Les emplacements ajustés de charnière dans la seconde image peuvent être utilisés pour déterminer des emplacements physiques du fixateur et des segments de la structure anatomique dans un espace tridimensionnel, lesquels peuvent être utilisés pour déterminer des manipulations sur le fixateur en vue de la correction d'une déformation.
Patent CA-3178588-A1 (CA)
Inventor: DUDLEY MARK EDWARD
IPC: C07K14/725
Filed: 2021-05-13
Abstract: The present invention relates to a method of treating, preventing or delaying the progression of cancer and/or tumour in a subject comprising administering to the subject a treatment regimen comprising an effective amount of modified immunoresponsive cells expressing or presenting a heterologous T-cell receptor (TCR) having the property of binding to MAGE A4
Patent CA-3179062-A1 (CA)
Title: Nanoparticulate formulation
Inventor: MOODY MARK
IPC: A61P35/00
Filed: 2022-10-11
Abstract: The present disclosure relates to nanoparticles and nanoparticulate compositions; methods of preparing such nanoparticles and nanoparticulate compositions; and associated methods of medical treatment and uses of such nanoparticles and nanoparticulate compositions for medical treatment, including the use of such nanoparticles for the manufacture of medicaments for medical treatment.
Patent CA-3183277-A1 (CA)
Title: Vertical cargo support system for a cargo space
Inventor: MUZYKA YAROSLOW I
IPC: B60P7/06
Filed: 2022-12-01
Abstract: A vertical cargo support system for use in a cargo space. A plurality of header beams is provided, extending across the shorter side of the cargo space, the header being supported by header brackets attached to vertically extending tracks of a support system, the track being attached to walls of the cargo space. At least one rail support extends downward from each header, the headers being aligned in rows. A rail, in the form of an elongated portion of a cylinder, rests in support rail rests in multiple rail supports. Cargo can be attached to rails by convenient means, such as hooks, straps, or the like. The load produced by the cargo is thus applied in turn to the rail, the rail support, the header, the header brackets, and the tracks.
Patent CA-3184207-A1 (CA)
Title: Ensemble membrane-joint d'etancheite
Inventor: COOLE JAKE
IPC: H01M8/0284
Filed: 2021-09-07
Abstract: La présente invention concerne un ensemble membrane-joint d'étanchéité qui comprend une région centrale, une région de bordure périphérique interne et une région de bordure périphérique externe, les régions de bordure périphérique interne et externe comprenant différents matériaux d'étanchéité.
Patent CA-3185597-A1 (CA)
Inventor: HICKS JACQUELINE D
IPC: A61K47/02
Filed: 2021-07-06
Abstract: The present invention provides a compound of Formula (I), and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing one or more disease states that could benefit from inhibition of plasma kallikrein, including hereditary angioedema, uveitis, posterior uveitis, wet age related macular edema, diabetic macular edema, diabetic retinopathy and retinal vein occlusion. The compounds are selective inhibitors of plasma kallikrein.
Patent CA-3187240-A1 (CA)
Title: Design of bacteriophage-based artificial viruses for human genome remodeling
Inventor: RAO VENIGALLA B
IPC: C12N15/86
Filed: 2021-07-21
Abstract: Described is an "artificial virus" (AV) programmed with biomolecules that can enter human cells and carry out precise human genome modification. The AVs comprise: at least one viral vector, such as bacteriophage T4; at least one therapeutic molecule, such as DNA, RNA, protein and their complex; and a lipid coating. Also described is a method of human genome modification, using such an AV, and a method of program such an AV.
Patent CA-3188105-A1 (CA)
Title: Methodes pour selectionner et traiter un cancer avec des d'inhibiteurs de fgfr3
Inventor: MILBURN MICHAEL
IPC: C12Q1/6869
Filed: 2021-06-22
Abstract: L'invention concerne des signatures d'activation de FGFR3 destinées à être utilisées dans des méthodes et des compositions pour prédire la réponse d'un patient souffrant d'un cancer à une thérapie par inhibiteurs de FGFR3.
Patent CA-3189598-A1 (CA)
Title: Medical device package with first use indicator label
Inventor: MCNULTY VIVIENNE
IPC: A61M25/00
Filed: 2021-09-01
Abstract: A package (10) for a medical product is provided. The medical package includes a case (12), a cap (14), a hinge (42) that connects the case to the cap and a first use indication label (16) that confirms whether a closed package has been previously opened. The first use indication label spans both an indentation (72) in the cap and an indentation (74) in the case.
Patent CA-3191147-A1 (CA)
Inventor: GELDER VINCENT DE
IPC: A01K5/00
Filed: 2021-08-20
Abstract: En particulier, la présente invention concerne un procédé d'amenée d'aliments pour l'élevage de larves d'insectes, ledit procédé comprenant les étapes consistant à (o) amener des aliments à un contenant à l'aide d'un moyen d'amenée grossière d'aliments, (i) déterminer, au niveau d'un moyen de détermination, la quantité d'aliments dans le contenant, (ii) calculer la quantité d'aliments nécessaire pour que la quantité totale d'aliments dans le contenant atteigne une quantité prédéfinie d'aliments, et (iii) amener des aliments au contenant selon la quantité calculée à l'étape (ii) à l'aide d'un moyen d'amenée précise d'aliments.
Patent CA-3192957-A1 (CA)
Title: Methods of preparing nicotinamide riboside and derivatives thereof
Inventor: MIGAUD MARIE
IPC: C07H19/048
Filed: 2014-07-24
Abstract: The invention relates to methods of preparing nicotinamide riboside and derivatives thereof. In an aspect, the invention relates to a method of preparing a compound of formula (I), wherein n is 0 or 1; m is 0 or 1; Y is 0 or S; R1 is selected from H, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted primary or secondary amino, and substituted or unsubstituted azido; R2-R5, which may be the same or different, are each independently selected from H, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, and substituted or unsubstituted aryl; and X- is an anion, selected from an anion of a substituted or unsubstituted carboxylic acid, a halide, a substituted or unsubstituted sulfonate, a substituted or unsubstituted phosphate, a substituted or unsubstituted sulfate, a substituted or unsubstituted carbonate, and a substituted or unsubstituted carbamate.
Patent CA-3197103-A1 (CA)
Inventor: SABERIDOKHT BAHARAK
IPC: G06F9/44
Filed: 2021-11-03
Abstract: Des systèmes et des procédés permettent une détection d'obscurcissement automatisée et évolutive dans des scripts de programmation, y compris des dispositifs de traitement qui reçoivent des scripts de programmation de logiciel et un ensemble de symboles. Les dispositifs de traitement déterminent une fréquence de chaque symbole et une fréquence moyenne des symboles dans le texte de script. Les dispositifs de traitement déterminent un score normal de chaque symbole sur la base de la fréquence de chaque symbole et de la fréquence moyenne pour créer une caractéristique de symbole de chaque symbole comprenant le score normal. Les dispositifs de traitement utilisent un modèle d'apprentissage machine d'obscurcissement comprenant un classificateur permettant d'effectuer une classification d'obscurcissement binaire pour détecter un obscurcissement dans le script sur la base des caractéristiques de symbole. Les dispositifs de traitement provoquent l'affichage d'une alerte indiquant un script de programmation de logiciel obscurci sur l'écran d'un dispositif informatique associé à un utilisateur administratif pour recommander une analyse de sécurité du script de programmation de logiciel sur la base de la classification d'obscurcissement binaire.
Patent CA-3202353-A1 (CA)
Inventor: DENER JEFFREY MARK
IPC: C07D239/54
Filed: 2021-12-20
Abstract: The present invention provides methods of preparing 2-amino-6-((1r,4r)-4-phenylcyclohexyl)-5-(3-(trifluoromethyl)benzyl)pyrimidin-4(3H)-one, and 2-amino-6-((1r,4r)-4-phenylcyclohexyl)-5-(3-(trifluoromethyl)benzyl)pyrimidin-4(3H)-one monohydrate, as well as new intermediate compounds.
Patent CA-3209327-A1 (CA)
Inventor: MA YIPING
IPC: A61B34/20
Filed: 2017-08-29
Abstract: A cover for magnetizing a shaft of a tissue-penetrating medical device is disclosed including a sleeve member having a hollow body to form a protective closure over the shaft of the tissue-penetrating medical device. The proximal end of the hollow body provides a receiving space for receiving the shaft of the tissue-penetrating medical device. One or more magnet is disposed on the sleeve member. A magnetic shield composed of one or more shielding materials associated with the cover that minimizes any effects to the clinical environment from magnetic fields generated within the cover. Medical devices and methods of magnetizing the shaft of a tissue-penetrating medical device using the cover are also disclosed.
Patent CA-3212539-A1 (CA)
Inventor: XU HAO
IPC: H04W72/23
Filed: 2014-09-18
Abstract: Certain aspects of the present disclosure generally relate to wireless communications, and more specifically, coverage enhancements for physical broadcast channel (PBCH). According to certain aspects, a method is provided for wireless communications by a user equipment (UE). The method generally includes receiving a physical downlink shared channel (PDSCH) transmission, receiving a different type downlink transmission, with transmit power boosted relative to the PDSCH  transmission, receiving information regarding relative transmit power of the PDSCH transmission relative to a common reference signal (CRS) based on the transmit power of the different type downlink transmission, and processing the PDSCH transmission based on the infomiation.
Patent CA-3214107-A1 (CA)
Inventor: PIN FREDERIC
IPC: C07D401/10
Filed: 2022-03-23
Abstract: The present invention relates to a new process for preparing 5-{5-chloro-2-[(3S)-3- [(morpholin-4-yl)methyl]-3,4-dihydroisoquinoline-2(1H)-carbonyl]phenyl}-1,2-dimethyl- 1H-pyrrole-3 -carboxylic acid derivatives and its application for the production of pharmaceutical compounds.
Patent CA-3215209-A1 (CA)
Title: Process, apparatus and system for the production, separation and purification of radioisotopes
Inventor: PAREKH SUNEEL NAVNITDAS
IPC: B01D7/00
Filed: 2022-03-18
Abstract: Process, Apparatus and System for the Production, Separation and Purification of Radioisotopes for medical, industrial, agricultural and energy applications.
Patent CA-3215575-A1 (CA)
Title: Solution electrolytique non aqueuse pour batterie secondaire au lithium et batterie secondaire au lithium la contenant
Inventor: KIM HAEUN
IPC: H01M10/0567
Filed: 2022-11-08
Abstract: L'invention concerne une solution électrolytique non aqueuse pour une batterie secondaire au lithium, cette solution électrolytique non aqueuse contenant un sel de lithium, un solvant organique et un additif de phosphate à structure spécifique. L'ajout d'un additif de phosphate selon un mode de réalisation de la présente invention à la solution électrolytique peut conduire à une amélioration significative de la stabilité à haute température d'une batterie secondaire au lithium.
Patent CA-3219380-A1 (CA)
Title: Systems and methods for the identification, evaluation, and/or closed-loop reprocessing of lumens
Inventor: SPARGO GAVIN
IPC: A61B90/98
Filed: 2022-06-09
Abstract: Systems and methods for identifying a fluidic configuration of a medical device having at least one lumen, identifying at least one lumen of a medical device, evaluating the integrity of a lumen of a medical device, and reprocessing a lumen of a medical device are presented. For example, these methods include flowing a fluid comprising a known specific gravity through the lumen, measuring the flow rate and/or pressure differential of the fluid being flowed through the lumen, and computing the flow coefficient of the lumen. The flow rate, pressure differential and/or computed flow coefficient may then be compared to known parameters for medical devices and their respective lumens to identify the medical device, each lumen, detect any faults, and/or irrigate the lumen with a fluid composition thereby reprocessing the medical device.
Patent CA-3219624-A1 (CA)
Title: Adjusting areas of interest for motion detection in camera scenes
Inventor: RAMANATHAN NARAYANAN
IPC: G06T7/50
Filed: 2022-05-09
Abstract: Disclosed are methods, systems, and apparatus for adjusting areas of interest for motion detection in camera scenes. A method includes obtaining a map of false motion event detections using a first area of interest; identifying an overlap area between the map of false detections and the first area of interest; determining a second area of interest that includes portions of the first area of interest and excludes at least a part of the overlap area; obtaining a map of true motion event detections using the first area of interest; determining whether true detections using the second area of interest compared to true detections using the first area of interest satisfies performance criteria; and in response to determining that true detections using the second area of interest compared to true detections using the first area of interest satisfies performance criteria, providing the second area of interest for use in detecting events.
Patent CA-3219827-A1 (CA)
Inventor: GARVEY TONY
IPC: G16H40/60
Filed: 2022-05-26
Abstract: Examples relate to devices, systems, and methods for collecting discharged fluids. A fluid collection system includes a fluid collection device configured to collect fluid discharged from a user and a fluid collection container configured to receive the fluid from the fluid collection device. The fluid collection system also includes a pump configured to pull an at least partial vacuum to draw the fluid from the fluid collection device and into the fluid collection container. The fluid collection system also includes a control system including at least one sensor configured to monitor at least one of a property or status of the fluid collection system and a controller operatively coupled to the at least one sensor and configured to communicate at least one of the property or the status of the fluid collection system to a control panel.
Patent CA-3220708-A1 (CA)
Inventor: GORMLEY NIALL ANTHONY
IPC: C12Q1/6806
Filed: 2022-05-26
Abstract: Des techniques d'acide nucléique sont divulguées. Des modes de réalisation comprennent des nucléotides 12 modifiés avec des adaptateurs 24 oligonucléotidiques qui sont couplés par l'intermédiaire de lieurs 20 clivables. L'incorporation du nucléotide 12 modifié à une extrémité 3' d'un acide nucléique permet une adaptation d'extrémité par la ligature d'une extrémité 5' libre de l'adaptateur 24 oligonucléotidique à un groupe réactif 3' du nucléotide 12 modifié et le clivage au niveau du lieur 20 clivable pour libérer une extrémité 3' libre.
Patent CA-3221521-A1 (CA)
Title: Hydroconversion of a hydrocarbon-based heavy feedstock in a hybrid ebullated-entrained bed, comprising premixing said feedstock with an organic additive
Inventor: MARQUES JOAO
IPC: C10G29/22
Filed: 2022-06-27
Abstract: The present invention relates to a process for the hydroconversion of a heavy feedstock comprising: (a) preparing a first conditioned feedstock (103) by mixing said hydrocarbon-based heavy feedstock (101) with an organic chemical compound (102) comprising at least one carboxylic acid function and/or at least one ester function and/or an acid anhydride function; (b) preparing a second conditioned feedstock (105) by mixing a catalyst precursor composition (104) with the first conditioned feedstock such that a colloidal or molecular catalyst is formed when said feedstock is reacted with sulphur; (c) heating the second conditioned feedstock in at least one preheater; (d) introducing the heated second conditioned feedstock (106) into at least one hybrid ebullated-entrained bed reactor comprising a porous supported hydroconversion catalyst and operating said reactor in the presence of hydrogen and under hydroconversion conditions in order to produce an upgraded material (107), wherein the colloidal or molecular catalyst is formed during step (c) and/or (d).
Patent CA-3221910-A1 (CA)
Inventor: BOWERS MIKE
IPC: E06B1/02
Filed: 2022-06-07
Abstract: L'invention concerne un système d'extension d'ouverture de bâtiment unifié 100 qui est préalablement construit hors site. Le système d'extension 100 fournit un ensemble étanche à l'air et étanche à l'eau qui est compatible avec des systèmes imperméabilisation à l'eau et à l'air intégrés à l'ensemble 100 lorsque l'ensemble d'ouverture 131 (par exemple porte ou fenêtre), l'isolation extérieure 303 et le placage 313 sont installés sur la paroi du bâtiment. L'intrusion ou des fuites d'eau sont évitées même dans des événements de pression d'air positive et négative (c'est-à-dire, vents et tempêtes). Une plaque de cloison 503 ayant un trou de mise à l'air 509 est ajustée sur un trou d'évacuation 171 au fond d'un cadre 101 de l'ensemble 100.
Patent CA-3223248-A1 (CA)
Title: Cuve a circulation comprenant un extincteur de signaux de fond
Inventor: BROWN ANDREW A
IPC: C12Q1/6818
Filed: 2022-09-28
Abstract: Un exemple de cuve à circulation comprend un substrat ayant une surface. La cuve à circulation comprend également un hydrogel polymère fixé à au moins une partie de la surface du substrat, l'hydrogel polymère comprenant un extincteur de signaux de fond. La cuve à circulation comprend en outre au moins un ensemble d'amorces fixé à l'hydrogel polymère.
Patent CA-3224071-A1 (CA)
Title: Product comprising a mineral wool to be blown
Inventor: RONY AMAURY
IPC: C03C13/06
Filed: 2022-07-21
Abstract: The present invention relates to a thermal insulation product comprising a mineral wool, said mineral wool including mineral fibres. According to the invention, the fibres have a fibre length population distribution such that the median fibre length in distribution number is less than or equal to 2 mm, and such that at least 10% of the number population has a fibre length strictly greater than 1.5 mm and preferably strictly greater than 2.0 mm, and the product contains at least one additive and has a total additive weight percent of between 0.4% and 1.2% inclusive, in particular between 0.6% and 1% inclusive.